156 related articles for article (PubMed ID: 29392968)
21. A validation study of a new prognostic index for patients with brain metastases: the Graded Prognostic Assessment.
Sperduto CM; Watanabe Y; Mullan J; Hood T; Dyste G; Watts C; Bender GP; Sperduto P
J Neurosurg; 2008 Dec; 109 Suppl():87-9. PubMed ID: 19123893
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors affecting the outcome of brain metastases from breast cancer.
Liu MT; Hsieh CY; Wang AY; Chang TH; Pi CP; Huang CC; Huang CY; Liou CH
Support Care Cancer; 2006 Sep; 14(9):936-42. PubMed ID: 16575571
[TBL] [Abstract][Full Text] [Related]
23. Validity of the graded prognostic assessment-derived index to predict brain-metastatic patients' survival after Gamma Knife radiosurgery.
Chiou SM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1156-62. PubMed ID: 20970031
[TBL] [Abstract][Full Text] [Related]
24. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
[TBL] [Abstract][Full Text] [Related]
25. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
[TBL] [Abstract][Full Text] [Related]
26. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
27. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
[TBL] [Abstract][Full Text] [Related]
28. The prognostic value of the Tau protein serum level in metastatic breast cancer patients and its correlation with brain metastases.
Darlix A; Hirtz C; Thezenas S; Maceski A; Gabelle A; Lopez-Crapez E; De Forges H; Firmin N; Guiu S; Jacot W; Lehmann S
BMC Cancer; 2019 Jan; 19(1):110. PubMed ID: 30700265
[TBL] [Abstract][Full Text] [Related]
29. Impact of non-small cell lung cancer histology on survival predicted from the graded prognostic assessment for patients with brain metastases.
Guo S; Reddy CA; Chao ST; Suh JH; Barnett GH; Vogelbaum MA; Videtic GM
Lung Cancer; 2012 Aug; 77(2):389-93. PubMed ID: 22542706
[TBL] [Abstract][Full Text] [Related]
30. Prediction of short survival in patients with brain metastases based on three different scores: a role for 'triple-negative' status?
Nieder C; Pawinski A; Molls M
Clin Oncol (R Coll Radiol); 2010 Feb; 22(1):65-9. PubMed ID: 19762219
[TBL] [Abstract][Full Text] [Related]
31. [Radiotherapy of brain metastases according to the GPA score (Graded Prognostic Assessment)].
Antoni D; Noël G
Cancer Radiother; 2013 Oct; 17(5-6):424-7. PubMed ID: 23973456
[TBL] [Abstract][Full Text] [Related]
32. Validation of the Disease-Specific GPA for Patients With 1 to 3 Synchronous Brain Metastases in Newly Diagnosed NSCLC.
Woody NM; Greer MD; Reddy CA; Videtic GMM; Chao ST; Murphy ES; Suh JH; Angelov L; Barnett GH; Vogelbaum MA; Stephans KL
Clin Lung Cancer; 2018 Jan; 19(1):e141-e147. PubMed ID: 28739316
[TBL] [Abstract][Full Text] [Related]
33. Does Graded Prognostic Assessment outperform Recursive Partitioning Analysis in patients with moderate prognosis brain metastases?
Estabrook NC; Lutz ST; Johnson CS; Lo SS; Henderson MA
CNS Oncol; 2016; 5(2):69-76. PubMed ID: 26985694
[TBL] [Abstract][Full Text] [Related]
34. The effect of non-small cell lung cancer histology on survival as measured by the graded prognostic assessment in patients with brain metastases treated by hypofractionated stereotactic radiotherapy.
Ma LH; Li G; Zhang HW; Wang ZY; Dang J; Zhang S; Yao L
Radiat Oncol; 2016 Jul; 11():92. PubMed ID: 27411944
[TBL] [Abstract][Full Text] [Related]
35. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
Patrikidou A; Chaigneau L; Isambert N; Kitikidou K; Shanley R; Ray-Coquard I; Valentin T; Malivoir B; Laigre M; Bay JO; Moureau-Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Guillemet C; Duffaud F; Hügli A; Le Pechoux C; Dhermain F; Blay JY; Sperduto PW; Le Cesne A
BMC Cancer; 2020 Feb; 20(1):117. PubMed ID: 32050939
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in patients treated with stereotactic image-guided robotic radiosurgery for brain metastases: a single-center retrospective analysis of 223 patients.
Pontoriero A; Conti A; Iatì G; Mondello S; Aiello D; Rifatto C; Risoleti E; Mazzei M; Tomasello F; Pergolizzi S; De Renzis C
Neurosurg Rev; 2016 Jul; 39(3):495-504. PubMed ID: 27106896
[TBL] [Abstract][Full Text] [Related]
37. Validation of the graded prognostic assessment index for surgically treated patients with brain metastases.
Nieder C; Geinitz H; Molls M
Anticancer Res; 2008; 28(5B):3015-7. PubMed ID: 19031949
[TBL] [Abstract][Full Text] [Related]
38. Clinical outcomes in patients with brain metastases from breast cancer treated with single-session radiosurgery or whole brain radiotherapy.
Mix M; Elmarzouky R; O'Connor T; Plunkett R; Prasad D
J Neurosurg; 2016 Dec; 125(Suppl 1):26-30. PubMed ID: 27903186
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for patients with newly diagnosed brain metastasis from breast cancer.
Castaneda CA; Flores R; Rojas KY; Castillo M; Dolores-Cerna K; Flores C; Belmar-Lopez C; Milla E; Gomez H
CNS Oncol; 2015; 4(3):137-45. PubMed ID: 25906174
[TBL] [Abstract][Full Text] [Related]
40. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.
Braccini AL; Azria D; Thezenas S; Romieu G; Ferreri JM; Jacot W
BMC Cancer; 2013 Feb; 13():70. PubMed ID: 23394467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
